Bivalent ligands as specific pharmacological tools for G protein-coupled receptor dimers
- PMID:19075611
- DOI: 10.2174/157016308786733591
Bivalent ligands as specific pharmacological tools for G protein-coupled receptor dimers
Abstract
G protein-coupled receptors (GPCRs) are major drug targets and are organized in dimeric/oligomeric complexes. These dimers may be composed of identical (homodimer) or different (heterodimer) receptors. GPCR dimerization provides new opportunities for drug design. Different strategies have been developed to specifically target GPCR dimers. Bivalent ligands, which are composed of two functional pharmacophores linked by a spacer, are among the most promising strategies. Due to the constitutive nature of GPCR dimers, bivalent ligands are expected in most cases to bind to and stabilize preexisting dimers rather then to promote ligand-induced dimerization. Most studies on GPCR dimerization were conducted so far in heterologous expression systems. Due the development of heterodimer-specific tools such as bivalent ligands, dimerization has now been confirmed for an increasing number of receptors in native tissues. In this review, we will discuss general considerations for the design and synthesis of bivalent ligands and present the functional in vitro and in vivo properties of reported bivalent ligands.
Similar articles
- Design of bivalent ligands targeting putative GPCR dimers.Huang B, St Onge CM, Ma H, Zhang Y.Huang B, et al.Drug Discov Today. 2021 Jan;26(1):189-199. doi: 10.1016/j.drudis.2020.10.006. Epub 2020 Oct 16.Drug Discov Today. 2021.PMID:33075471Free PMC article.Review.
- Dopamine D2 Receptors Dimers: How can we Pharmacologically Target Them?Carli M, Kolachalam S, Aringhieri S, Rossi M, Giovannini L, Maggio R, Scarselli M.Carli M, et al.Curr Neuropharmacol. 2018 Jan 30;16(2):222-230. doi: 10.2174/1570159X15666170518151127.Curr Neuropharmacol. 2018.PMID:28521704Free PMC article.Review.
- Study of G protein-coupled receptors dimerization: From bivalent ligands to drug-like small molecules.Qian M, Sun Z, Chen X, Van Calenbergh S.Qian M, et al.Bioorg Chem. 2023 Nov;140:106809. doi: 10.1016/j.bioorg.2023.106809. Epub 2023 Aug 26.Bioorg Chem. 2023.PMID:37651896Review.
- Physiological relevance of GPCR oligomerization and its impact on drug discovery.Panetta R, Greenwood MT.Panetta R, et al.Drug Discov Today. 2008 Dec;13(23-24):1059-66. doi: 10.1016/j.drudis.2008.09.002. Epub 2008 Oct 14.Drug Discov Today. 2008.PMID:18824244Review.
- Developing a Biased Unmatched Bivalent Ligand (BUmBL) Design Strategy to Target the GPCR Homodimer Allosteric Signaling (cAMP over β-Arrestin 2 Recruitment) Within the Melanocortin Receptors.Lensing CJ, Freeman KT, Schnell SM, Speth RC, Zarth AT, Haskell-Luevano C.Lensing CJ, et al.J Med Chem. 2019 Jan 10;62(1):144-158. doi: 10.1021/acs.jmedchem.8b00238. Epub 2018 May 9.J Med Chem. 2019.PMID:29669202Free PMC article.
Cited by
- Chemical biology-based approaches to study adenosine A2A - dopamine D2 receptor heteromers.Gregory KJ, Jörg M.Gregory KJ, et al.Purinergic Signal. 2022 Dec;18(4):395-398. doi: 10.1007/s11302-022-09860-8. Epub 2022 Mar 29.Purinergic Signal. 2022.PMID:35348986Free PMC article.No abstract available.
- Drug discovery research targeting the CXC chemokine receptor 4 (CXCR4).Choi WT, Duggineni S, Xu Y, Huang Z, An J.Choi WT, et al.J Med Chem. 2012 Feb 9;55(3):977-94. doi: 10.1021/jm200568c. Epub 2011 Dec 2.J Med Chem. 2012.PMID:22085380Free PMC article.Review.No abstract available.
- Orphan G Protein Coupled Receptors in Affective Disorders.Watkins LR, Orlandi C.Watkins LR, et al.Genes (Basel). 2020 Jun 24;11(6):694. doi: 10.3390/genes11060694.Genes (Basel). 2020.PMID:32599826Free PMC article.Review.
- Role of antibodies in developing drugs that target G-protein-coupled receptor dimers.Hipser C, Bushlin I, Gupta A, Gomes I, Devi LA.Hipser C, et al.Mt Sinai J Med. 2010 Jul-Aug;77(4):374-80. doi: 10.1002/msj.20199.Mt Sinai J Med. 2010.PMID:20687183Free PMC article.Review.
- Bitopic ligands: all-in-one orthosteric and allosteric.Kamal M, Jockers R.Kamal M, et al.F1000 Biol Rep. 2009 Oct 14;1:77. doi: 10.3410/B1-77.F1000 Biol Rep. 2009.PMID:20948611Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources